La esclerosis sistémica (ES) puede afectar al pericardio, el miocardio, las arterias coronarias, el sistema de conducción y las válvulas cardíacas. La presencia. El objetivo de esta revisión es analizar las diferencias en la epidemiología, las manifestaciones clínicas y la gravedad de la esclerosis sistémica en los. La esclerosis sistémica es una enfermedad autoinmune del tejido conectivo, que se caracteriza por un depósito excesivo de tejido colágeno y otros.

Author: Maunos Shaktikree
Country: Uruguay
Language: English (Spanish)
Genre: Environment
Published (Last): 21 May 2006
Pages: 293
PDF File Size: 20.42 Mb
ePub File Size: 12.11 Mb
ISBN: 625-1-41181-304-6
Downloads: 42449
Price: Free* [*Free Regsitration Required]
Uploader: Jugrel

Rheumatology, 39pp. Effect of the calcium channel blocker nifedipine on Raynaud’s phenomenon. Trial of platelet-inhibiting during in scleroderma. Rheumatology, sistwmicapp. Raynaud’s Phenomenon and the role of capillaroscopy. Scand J Rheumatol, 33pp. La causa de la esclerodermia no se conoce. Differential inhibition by botulinum neurotoxin A of cotransmitters released from autonomic vasodilator neurons.

Suclinical hypothyroidism and risk of heart failure, other cardiovascular events, and death. Important complications of fibrosis include left ventricular hypertrophy, as well as systolic and diastolic dysfunction of both ventricles.


Clin Exp Rheumatol, 18pp. Oral sildenafil for the treatment of Raynaud’s phenomenon and digital ulcers secondary to systemic sclerosis. Prevalence and clinical characteristics in a series of patients. Rheum Dis Clin North Am, 22pp. Osteoporosis — less than expected in patients with scleroderma.

Dis Colon Rectum, 44pp. Treatment of Raynaud’s phenomenon by intravenous infusion of prostacyclin PGI2. Thyroid disease in progressive systemic sclerosis: Comparative esophageal and anorectal motility in scleroderma. Gastric antral estasia watermelon stomach in patients with systemic sclerosis. J Clin Pharm Ther, 13pp. Diagnosis, prophylaxis and treatment of osteoporosis.

Alteraciones endocrinas en la esclerosis sistémica | Reumatología Clínica

Dig Dis, 18pp. Am J Med,pp.

Ann Rheum Dis, 61pp. Symptoms of Raynaud phenomenon in an inner-city African-American community. SRJ is a prestige metric based on the idea that not all citations are the same. Endothelin and endothelin receptor antagonists in systemic rheumatic diseases [review]. Arthritis Rheum, 40pp. Nailfold videocapillaroscopy assessment of microvascular damage in systemic sclerosis. Continuing navigation will be considered as acceptance of this use. Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease.


Am J Gastrenterol, 89pp.

Intravenous iloprost treatment of Raynaud’s phenomenon and ischemic ulcers secondary to systemic sclerosis. Clin Exp Rheumatol, 23pp. JDDG, 5pp. Subjective and objective assessment of enalapril in primary Raynaud’s phenomenon.

Prevalence of Raynaud’s phenomenon in a healthy Spanish population. Am Fam Wsclerosis, 72pp. Arthritis Rheum, 43pp.

It is important to run thyroid function test and to investigate the manifestation of clinical and subclinical hypothyroidism and to initiate treatment with levothyroxine. J Rheumatol, 27pp. Cytomegalovirus esophagitis as a treatable complication of systemic sclerosis.

Am J Med, 46pp. Hasta el momento, no se ha logrado identificar el origen de estas diferencias. Severe digital ischaemia treated with phosphodiesterase inhibitors. J Rheumatol, 11pp. Scleroderma, fibroblasts, signaling, and excessive extracellular matrix.

This item has received. Minerva Cardioangiol, 47pp. Functional foods and probiotic: